ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||
abnormal apoptosis
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Alox15 | arachidonate 15-lipoxygenase |
|
IED | 10 | 57,185,939 | 57,194,388 | RGD:704402 | RGD | ||
| G | Bcl2l11 | BCL2-like 11 (apoptosis facilitator) |
|
IED | 3 | 115,692,323 | 115,722,701 | RGD:704413 | RGD | ||
| G | C9 | complement component 9 |
|
IED | 2 | 55,743,084 | 55,791,148 | RGD:704414 | RGD | ||
| G | Calr | calreticulin |
|
IED | 19 | 24,964,775 | 24,969,670 | RGD:704416 | RGD | ||
| G | Crh | corticotropin releasing hormone |
|
IED | 2 | 104,764,023 | 104,765,887 | RGD:704423 | RGD | ||
| G | Fn1 | fibronectin 1 |
|
IEA | 9 | 70,702,181 | 70,771,155 | RGD:704404 | RGD | ||
abnormal cell death
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Aif1 | allograft inflammatory factor 1 |
|
IED | 20 | 3,714,428 | 3,716,327 | RGD:704401 | RGD | ||
abnormal cellular cholesterol metabolism
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Hpcl1 | Hepatic cholesterol level QTL 1 |
|
IAGP | 10 | 36,649,906 | 53,800,677 | RGD:629576 | RGD | ||
abnormal cellular respiration
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Myc | myelocytomatosis oncogene |
|
IMP | 7 | 98,953,142 | 98,958,060 | RGD:7207891 | RGD | ||
abnormal lymphopoiesis
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | WIN/RhwRrrc | TAS | RGD:2292495 | RGD | |||||||
abnormal mononuclear cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | BN | BN | TAS | RGD:1004 | RGD | ||||||
abnormal neural crest cell migration
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Fgfr1 | Fibroblast growth factor receptor 1 |
|
IEA | 16 | 70,869,974 | 70,910,045 | RGD:704404 | RGD | ||
abnormal neuronal migration
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Gfra3 | GDNF family receptor alpha 3 |
|
IEA | 18 | 27,167,576 | 27,195,848 | RGD:704404 | RGD | ||
abnormal osteoclast differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | LEW-tl | IED | RGD:619693 | RGD | |||||||
abnormal retinal apoptosis
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Hras | Harvey rat sarcoma virus oncogene |
|
IED | 1 | 201,385,705 | 201,388,987 | RGD:1358731 | RGD | ||
abnormal T cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | WKAH.LEC-Ptprkthid/Tj |
|
TAS | 1 | 17,328,563 | 17,752,200 | RGD:1302502 | RGD | |||
decreased angiotensin I-converting enzyme activity
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | F344-Tg(Cyp1a1-Ren2)10Jmul | IED | RGD:2313695 | RGD | |||||||
| S | LEW-Chr YF344/Jmul | IED | RGD:2313695 | RGD | |||||||
decreased apoptosis
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Hcar15 | Hepatocarcinoma resistance QTL 15 |
|
IAGP | 1 | 156,124,624 | 247,322,277 | RGD:1358145 | RGD | ||
decreased cell proliferation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | F344.BN-(D3Mgh13-D3Mgh7)/Dlw |
|
IED | 3 | 112,319,451 | 112,319,585 | RGD:1581610 | RGD | |||
decreased fibroblast proliferation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Myc | myelocytomatosis oncogene |
|
IMP | 7 | 98,953,142 | 98,958,060 | RGD:7207891 | RGD | ||
decreased neuron apoptosis
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Ednrb | endothelin receptor type B |
|
IPM | 15 | 87,893,141 | 87,898,700 | RGD:4892578 | RGD | ||
enhanced cellular glucose import
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Myc | myelocytomatosis oncogene |
|
IMP | 7 | 98,953,142 | 98,958,060 | RGD:7207891 | RGD | ||
increased angiotensin I-converting enzyme activity
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | LOU.BN-(D10Mgh1-D10Mgh14)/Ins |
|
IED | 10 | 65,379,850 | 65,379,965 | RGD:2293119 | RGD | |||
increased apoptosis
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Psen1 | presenilin 1 |
|
IED | 6 | 107,737,543 | 107,776,357 | RGD:1304239 | RGD | ||
increased cell proliferation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Ccnd1 | cyclin D1 |
|
IED | 1 | 205,357,235 | 205,366,757 | RGD:704417 | RGD | ||
| G | Ednrb | endothelin receptor type B |
|
IPM | 15 | 87,893,141 | 87,898,700 | RGD:4892578 | RGD | ||
| G | Fgfr1 | Fibroblast growth factor receptor 1 |
|
IEA | 16 | 70,869,974 | 70,910,045 | RGD:704404 | RGD | ||
increased cellular sensitivity to X-ray irradiation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Xhs1 | X-ray hypersensitivity QTL 1 |
|
QTM | 4 | 82,861,630 | 155,893,772 | RGD:69702 | RGD | ||
| Q | Xhs2 | X-ray hypersensitivity QTL 2 |
|
QTM | 1 | 15,833,442 | 19,577,925 | RGD:69702 | RGD | ||
| Q | Xhs3 | X-ray hypersensitivity QTL 3 |
|
QTM | 4 | 84,355,208 | 131,969,855 | RGD:631318 | RGD | ||
increased double-negative T cell number
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Neudeg2 | Neurodegradation QTL 2 |
|
IAGP | 5 | 25,602,274 | 45,822,846 | RGD:1358788 | RGD | ||
| Q | Neuinf1 | Neuroinflammation QTL 1 |
|
IAGP | 5 | 161,449,395 | 173,096,209 | RGD:1358788 | RGD | ||
increased hepatocyte proliferation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Hcas8 | Hepatocarcinoma susceptibility QTL 8 |
|
IED | 16 | 1 | 24,132,402 | RGD:1599590 | RGD | ||
| S | F344.BN-(D16Mit5-D16Rat75) |
|
IED | 16 | 24,131,965 | 24,132,402 | RGD:1599590 | RGD | |||
increased T cell proliferation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| Q | Ean2 | Experimental allergic neuritis QTL 2 |
|
IED | 4 | 82,700,691 | 96,313,512 | RGD:2306769 | RGD | ||
| Q | Ean4 | Experimental allergic neuritis QTL 4 |
|
IED | 10 | 87,849,516 | 98,392,508 | RGD:2306769 | RGD | ||
| Q | Ean5 | Experimental allergic neuritis QTL 5 |
|
IED | 10 | 76,043,832 | 98,392,296 | RGD:2306769 | RGD | ||
lysosomal protein accumulation
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | Gusb | glucuronidase, beta |
|
IEA | 12 | 27,744,409 | 27,757,755 | RGD:704404 | RGD | ||
oxidative stress
| |||||||||||
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| S | CRDH | Cohen Rosenthal Diabetic Hypertensive | TAS | RGD:1354689 | RGD | ||||||
| S | SHRSP/Gcrc | Spontaneously hypertensive rat, stroke prone | TAS | RGD:2301356 | RGD | ||||||
Term paths to the root
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term